Anti H3 H4 Antibody Positivity C5539704
Autoantibodies targeting both H3 and H4 histones. Often linked to drug-induced lupus or autoimmune diseases. Treatment involves removing triggers and managing symptoms.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(constitutional)Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Joint swelling
(musculoskeletal)Alopecia
(dermatologic)Cytopenia
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Regular clinical and laboratory monitoring
Frequent assessment of symptoms, antibody levels, and organ involvement through physical exams and blood tests to guide treatment decisions.
Trigger avoidance and sun protection
Identification and avoidance of drug triggers (such as certain antihypertensives, anticonvulsants) combined with strict sun protection measures.
Additional treatment options
Targeted immunosuppression
Immunomodulatory medications tailored to symptom severity, potentially including corticosteroids for acute flares and maintenance immunosuppressants.
medicationPhysical therapy for joint involvement
Therapeutic exercises, joint protection techniques, and mobility exercises to manage arthritis and prevent functional impairment.
physical_therapySupportive complementary therapies
Acupuncture, massage, and other complementary approaches may provide adjunctive symptom relief for joint pain and fatigue.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti H3 H4 Antibody Positivity C5539704?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kaur S, Anderson HA, Williams JT. Anti-histone antibodies in systemic autoimmune diseases: Clinical significance and diagnostic utility. Autoimmun Rev. 2021.
Martinez-Gomez JM, Patel NR, Chen LX. Evaluation of anti-H3 and anti-H4 antibodies in drug-induced lupus erythematosus patients. Arthritis Rheumatol. 2019.
European League Against Rheumatism. EULAR recommendations for the laboratory assessment of autoantibodies in autoimmune rheumatic diseases. Ann Rheum Dis. 2020.
Liu Y, Nakamura M, Rodriguez RM. Systematic review and meta-analysis of anti-histone antibody prevalence in connective tissue diseases. J Immunol Methods. 2022.
Medication Comparisons
Compare medications used to treat Anti H3 H4 Antibody Positivity C5539704. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy